232 related articles for article (PubMed ID: 29082287)
1. Flow Cytometric Analysis of HIV-1 Transcriptional Activity in Response to shRNA Knockdown in A2 and A72 J-Lat Cell Lines.
Boehm D; Ott M
Bio Protoc; 2017 Jun; 7(11):. PubMed ID: 29082287
[TBL] [Abstract][Full Text] [Related]
2. Flow Cytometric Analysis of Drug-induced HIV-1 Transcriptional Activity in A2 and A72 J-Lat Cell Lines.
Boehm D; Ott M
Bio Protoc; 2017 May; 7(10):. PubMed ID: 28835903
[TBL] [Abstract][Full Text] [Related]
3. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
[TBL] [Abstract][Full Text] [Related]
4. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
J Virol; 2018 May; 92(10):. PubMed ID: 29343578
[TBL] [Abstract][Full Text] [Related]
5. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
[TBL] [Abstract][Full Text] [Related]
6. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
7. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
Li Z; Guo J; Wu Y; Zhou Q
Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
[TBL] [Abstract][Full Text] [Related]
8. Specific Activation
Li G; Zhang Z; Reszka-Blanco N; Li F; Chi L; Ma J; Jeffrey J; Cheng L; Su L
J Virol; 2019 Jun; 93(12):. PubMed ID: 30971469
[TBL] [Abstract][Full Text] [Related]
9. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
10. FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.
Huang H; Santoso N; Power D; Simpson S; Dieringer M; Miao H; Gurova K; Giam CZ; Elledge SJ; Zhu J
J Biol Chem; 2015 Nov; 290(45):27297-27310. PubMed ID: 26378236
[TBL] [Abstract][Full Text] [Related]
11. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q
PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085
[TBL] [Abstract][Full Text] [Related]
12. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal.
Matsuda K; Kobayakawa T; Tsuchiya K; Hattori SI; Nomura W; Gatanaga H; Yoshimura K; Oka S; Endo Y; Tamamura H; Mitsuya H; Maeda K
J Biol Chem; 2019 Jan; 294(1):116-129. PubMed ID: 30413535
[TBL] [Abstract][Full Text] [Related]
13. A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association.
Huang H; Liu S; Jean M; Simpson S; Huang H; Merkley M; Hayashi T; Kong W; Rodríguez-Sánchez I; Zhang X; Yosief HO; Miao H; Que J; Kobie JJ; Bradner J; Santoso NG; Zhang W; Zhu J
Front Microbiol; 2017; 8():1035. PubMed ID: 28638377
[TBL] [Abstract][Full Text] [Related]
14. A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP.
Wang C; Yang S; Lu H; You H; Ni M; Shan W; Lin T; Gao X; Chen H; Zhou Q; Xue Y
PLoS One; 2015; 10(11):e0142739. PubMed ID: 26569506
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.
Jiang G; Mendes EA; Kaiser P; Sankaran-Walters S; Tang Y; Weber MG; Melcher GP; Thompson GR; Tanuri A; Pianowski LF; Wong JK; Dandekar S
AIDS; 2014 Jul; 28(11):1555-66. PubMed ID: 24804860
[TBL] [Abstract][Full Text] [Related]
16. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
Rochat MA; Schlaepfer E; Speck RF
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of HIV latency.
Cary DC; Fujinaga K; Peterlin BM
J Clin Invest; 2016 Feb; 126(2):448-54. PubMed ID: 26731470
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Promotes HIV-1 Tat Accumulation via AKT/FOXO1 Signaling Axis and Potentiates Vorinostat to Antagonize HIV-1 Latency.
Feng Z; Yang Z; Gao X; Xue Y; Wang X
Curr HIV Res; 2021; 19(3):238-247. PubMed ID: 33461468
[TBL] [Abstract][Full Text] [Related]
19. The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.
Conrad RJ; Fozouni P; Thomas S; Sy H; Zhang Q; Zhou MM; Ott M
Mol Cell; 2017 Sep; 67(6):1001-1012.e6. PubMed ID: 28844864
[TBL] [Abstract][Full Text] [Related]
20. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.
Hokello J; Sharma AL; Tyagi M
Viruses; 2020 Aug; 12(8):. PubMed ID: 32784426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
